A lower activity of PON-1 has been observed in various autoimmune diseases such as systemic lupus erythematosus [27], primary and secondary antiphospholipid syndrome [28,29], and functional and structural abnormalities of arteries, such as atherosclerotic lesions [30] or ischemic stroke [31]. This evidence concerns the gene PON1 and systemic lupus erythematosus.